Author:
Martins Thiago Gonçalves dos Santos
Publisher
Springer Science and Business Media LLC
Reference9 articles.
1. Chu WK, Choi HL, Bhat AK, Jhanji V. Pterygium: new insights. Eye. 2020;34:1047–50. https://doi.org/10.1038/s41433-020-0786-3.
2. Mansour AM. Treatment of inflamed pterygia or residual pterygial bed. Br J Ophthalmol. 2009;93:864–65. https://doi.org/10.1136/bjo.2008.155291.
3. Hussain Z, Rehman HUBM. Comparison of preoperative injection vs. intraoperative application of mitomycin C in recurrent pterygium. Ophthalmol Updat. 2013;11:21–4.
4. Wanzeler ACV, Barbosa IAF, Duarte B, Borges D, Barbosa EB,Kamiji D, et al. Mechanisms and biomarker candidates in pterygium development. Arq Bras Oftalmol. 2019;82:528–36. https://doi.org/10.5935/0004-2749.20190103.
5. Ucuzian AA, Bufalino DV, Pang Y, Greisler HP. Angiogenic endothelial cell invasion into fibrin is stimulated by proliferating smooth muscle cells. Microvasc Res. 2013;90:40–7. https://doi.org/10.1016/j.mvr.2013.06.012.